Condition: Sickle Cell Trait · Sponsor: National Alliance for Sickle Cell Centers
The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.
This description comes directly from the study's public registry record.
Julie Kanter, MD · (202) 596-1548 · jkanter@sicklecellcenters.org
Always discuss trial participation with your own doctor first.
| University of Alabama | Birmingham, Alabama, United States | Recruiting |
| Loma Linda University Health Care | Loma Linda, California, United States | Recruiting |
| Nemours Children's Hospital | Wilmington, Delaware, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| Functional Fluidics | Detroit, Michigan, United States | Recruiting |
| University of North Carolina | Chapel Hill, North Carolina, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
| East Carolina University | Greenville, North Carolina, United States | Recruiting |
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
| UT Health Houston | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06071377